PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke , Sherbrooke (Québec), Canada.\', \'Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke , Sherbrooke (Québec), Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/13543776.2020.1817390
?:hasPublicationType
?:journal
  • Expert opinion on therapeutic patents
is ?:pmid of
?:pmid
?:pmid
  • 32887532
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.926
?:rankingScore_hIndex
  • 59
?:title
  • Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract - A review of patent literature.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32887532>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32887532>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all